Cantor Fitzgerald analysts paint a grim picture for equity markets ( SP500 ), ( COMP:IND ), ( DJI ), pointing to ...

Fintel reports that on April 22, 2025, Cantor Fitzgerald initiated coverage of AbbVie (NYSE:ABBV) with a Overweight ...

President Trump is relying on a cast of economic advisers with differing viewpoints and backgrounds as he implements a ...

Cantor Fitzgerald assumed coverage of Bristol Myers (BMY) with a Neutral rating and $55 price target Following the Cobenfy for schizophrenia ...

The most talked about and market moving research calls around Wall Street are now in one place. Here are today's research ...

Verve Therapeutics (VERV) stock surged as promising trial data for cholesterol therapy VERVE-102 prompted Cantor Fitzgerald ...

An earnings preview of Tesla shows the company has missed Street estimates for revenue and earnings per share in six of the ...

Spending cuts and directives questioning the reality and urgency of climate change have marked quick shifts in U.S. science ...

For now, it’s up to the courts whether the Trump administration can continue on a path of dramatically downsizing the bureau.

Cantor Fitzgerald analyst C J Muse reiterated a Buy rating on Nvidia (NVDA – Research Report) yesterday and set a price target of $200.00.Stay ...

Cantor Fitzgerald analyst D. Mathivanan now forecasts that the business services provider will post earnings per share of $197.85 for the year, down from their prior estimate of $208.81.